Dotbee.ai

Analysis Aura Biosciences, Inc. (AURA)

6/4/2024

Analysis Aura Biosciences, Inc. (AURA)

Analysis of Aura Biosciences, Inc. (AURA)

Aura Biosciences, Inc. is showing some interesting trends based on the provided data:

1. **Price Movement**: The closing prices have been fluctuating between $7.17 and $14.00 over the past few days, indicating some volatility in the stock.

2. **Relative Strength Index (RSI)**: The RSI values are mostly around 50, suggesting that the stock is neither overbought nor oversold. This indicates a balanced market sentiment.

3. **Moving Average Convergence Divergence (MACD)**: The MACD indicator is positive, with the MACD line consistently above the signal line. This could indicate a bullish trend in the stock price.

4. **Moving Averages (MA)**: The stock's closing prices are generally above the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) values, which could suggest a positive momentum.

Overall, based on the RSI, MACD, and MA indicators, Aura Biosciences, Inc. seems to be in a relatively stable position with potential for a bullish trend in the near future. However, investors should closely monitor the price movements and key indicators for any significant changes.

Earnings

The company's results for the most recent quarter ending on April 30, 2025, have not been provided at this time. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results for October 31, 2024, were not provided at the time. On August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.

Main Statystic 🧠

The data provided includes financials, stock statistics, valuations metrics, stock price summary, and dividends and splits information for a specific company.

In terms of financials, the company has a strong operating cash flow and levered free cash flow. The balance sheet shows a healthy current ratio, but a high total debt to equity ratio. The profit margin and operating margin are both positive, indicating profitability. The company's fiscal year ends in September 2023, with notable figures such as revenue, EBITDA, and net income.

Moving on to stock statistics, we see details such as short ratio, float shares, shares outstanding, and insider and institutional ownership percentages. The valuations metrics provide insights into the company's valuation multiples, such as P/E ratio, PEG ratio, and price to book ratio. The enterprise value, market capitalization, and other key metrics are also included.

The stock price summary section covers information like beta, moving averages, and the company's 52-week high and low prices. Lastly, the dividends and splits data includes details on dividend rates, payout ratios, dividend yield, and historical split information.

Overall, these data points offer a comprehensive overview of the company's financial health, stock performance, valuation, and dividend history.

Income statement 💸

These are the revenue figures. Here are the conclusions:

1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. The gross profit margin has been relatively stable, with gross profit ranging from around $105 billion to $169 billion.
3. Operating income has also shown an increasing trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
4. Net income has been growing consistently, with the company reporting a net income of $57.4 billion in 2020 and $97 billion in 2023.
5. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years.
6. The company has been able to maintain a healthy EBITDA margin, with EBITDA ranging from $81 billion to $129 billion.
7. Despite fluctuations in certain expenses and income components, the overall financial performance of the company seems to be on an upward trajectory.

Balance Sheet

These are balance sheets. Here are the conclusions:

1. The total assets have been increasing over the years, from $323.9 billion in 2018 to $352.8 billion in 2023.
2. Current assets have fluctuated but generally increased, with the highest value in 2023 at $143.6 billion.
3. Non-current assets have also shown an increasing trend, reaching $209 billion in 2023.
4. Total liabilities have been increasing steadily, from $248 billion in 2019 to $290.4 billion in 2023.
5. Shareholders' equity has shown an increasing trend, with fluctuations, reaching $62.1 billion in 2023.
6. The company has been relying more on non-current assets to support its growth, as seen in the increasing trend of non-current assets compared to current assets.
7. The company has been financing its growth through a combination of debt and equity, as indicated by the increase in both liabilities and shareholders' equity over the years.

Cash Flow 💶

This is a cash flow statement. Here are some conclusions we can draw from the data:

1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with some fluctuations in different areas that may require further analysis.

Earnings estimate

Based on the analysts' estimates for future quarterly and annual earnings per share (EPS), we can draw the following conclusions:

1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. Compared to the EPS of $1.17 from a year ago, there is expected growth.

2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also shows an increase from the EPS of $1.35 reported a year ago.

3. Looking at the estimates for the current fiscal year ending on September 30, 2024, analysts predict an average EPS of $6.10, ranging from $5.95 to $6.41. This indicates growth compared to the EPS of $5.67 from the previous year.

4. For the next fiscal year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests further growth from the expected EPS for the current fiscal year.

Overall, the analysts' estimates point towards a positive outlook with expected earnings growth in both the upcoming quarters and the next fiscal year.

Revenue estimate

Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:

1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.

2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.

3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.

4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.

Overall, the analysts are generally optimistic about the company's future sales performance, with moderate growth expected in both the quarterly and annual sales figures.

Growth estimates

Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:

1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.

These estimates suggest that the company has been experiencing strong growth in the past, and analysts expect this growth to continue at a slightly lower but still healthy rate in the coming years.

Price target

The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25

Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median and average price above the current price. However, there is a wide range between the low and high forecasts, indicating some uncertainty or differing opinions among analysts.

MACD of AURA

This is not investment advice. Remember to verify the information provided here.

Get access to the full analysis

  • Over 35 000 indexes
  • CFD, Forex, Crypto and Stocks Exchange
  • Over 150 Indicators
  • Pattern and candle analysis
  • Support and resistance levels
  • Fundamental, technical and sentimental analysis
  • Power from AI
Web versionApp StoreGoogle Play

Contacts

Telephone number

+48 32 700 81 66

Email address

[email protected]

Company information

Honey Payment Group S.A. at Al. Aleje Jerozolimskie 65 / 79, 00-697 Warsaw, Poland, Register number KRS 0000335507, NIP 5252859204, REGON 388760204. Honey Payment Group is listed on the Warsaw Stock Exchange (WSE) under the ticker symbol HPG. Link